A novel homozygous mutation of the nicotinamide nucleotide transhydrogenase gene in a Japanese patient with familial glucocorticoid deficiency

Rie Yamaguchi, Fumiko Kato, Tomonobu Hasegawa, Noriyuki Katsumata, Maki Fukami, Toshiharu Matsui, Keisuke Nagasaki, Tsutomu Ogata

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

Familial glucocorticoid deficiency (FGD) is a rare autosomal recessive disorder characterized by primary hypocortisolism and normal mineralocorticoid production. Recently, NNT encoding the nicotinamide nucleotide transhydrogenase has been identified as a causative gene for FGD. Thus, we examined NNT in six Japanese FGD patients with no recognizable mutation in the previously known four responsible genes for FGD (MC2R, MRAP, STAR, and MCM4), and identified a novel homozygous substitution (c.644T>C; p.Phe215Ser) in a single 17.5-year-old boy. His parents were heterozygous for this mutation. This substitution was absent from 120 Japanese control subjects and was not registered in public databases including JSNP Database. The phenylalanine residue at the 215th codon was evolutionally conserved, and the p.Phe215Ser was assessed to be a pathologic mutation by in silico protein function analyses. The results, in conjunction with the previous data, imply that NNT mutations account for 5-10% of FGD patients, and that underlying factor(s) still remains to be clarified in a substantial fraction of FGD patients.

Original languageEnglish
Pages (from-to)855-859
Number of pages5
JournalEndocrine Journal
Volume60
Issue number7
DOIs
Publication statusPublished - 2013

Fingerprint

NADP Transhydrogenases
Glucocorticoids
Mutation
Genes
Databases
Mineralocorticoids
Phenylalanine
Codon
Computer Simulation
Parents

Keywords

  • Familial glucocorticoid deficiency
  • In silico functional analysis
  • NNT

ASJC Scopus subject areas

  • Endocrinology
  • Endocrinology, Diabetes and Metabolism

Cite this

A novel homozygous mutation of the nicotinamide nucleotide transhydrogenase gene in a Japanese patient with familial glucocorticoid deficiency. / Yamaguchi, Rie; Kato, Fumiko; Hasegawa, Tomonobu; Katsumata, Noriyuki; Fukami, Maki; Matsui, Toshiharu; Nagasaki, Keisuke; Ogata, Tsutomu.

In: Endocrine Journal, Vol. 60, No. 7, 2013, p. 855-859.

Research output: Contribution to journalArticle

Yamaguchi, Rie ; Kato, Fumiko ; Hasegawa, Tomonobu ; Katsumata, Noriyuki ; Fukami, Maki ; Matsui, Toshiharu ; Nagasaki, Keisuke ; Ogata, Tsutomu. / A novel homozygous mutation of the nicotinamide nucleotide transhydrogenase gene in a Japanese patient with familial glucocorticoid deficiency. In: Endocrine Journal. 2013 ; Vol. 60, No. 7. pp. 855-859.
@article{c736dccc8f2b43bdb49788724a50b58c,
title = "A novel homozygous mutation of the nicotinamide nucleotide transhydrogenase gene in a Japanese patient with familial glucocorticoid deficiency",
abstract = "Familial glucocorticoid deficiency (FGD) is a rare autosomal recessive disorder characterized by primary hypocortisolism and normal mineralocorticoid production. Recently, NNT encoding the nicotinamide nucleotide transhydrogenase has been identified as a causative gene for FGD. Thus, we examined NNT in six Japanese FGD patients with no recognizable mutation in the previously known four responsible genes for FGD (MC2R, MRAP, STAR, and MCM4), and identified a novel homozygous substitution (c.644T>C; p.Phe215Ser) in a single 17.5-year-old boy. His parents were heterozygous for this mutation. This substitution was absent from 120 Japanese control subjects and was not registered in public databases including JSNP Database. The phenylalanine residue at the 215th codon was evolutionally conserved, and the p.Phe215Ser was assessed to be a pathologic mutation by in silico protein function analyses. The results, in conjunction with the previous data, imply that NNT mutations account for 5-10{\%} of FGD patients, and that underlying factor(s) still remains to be clarified in a substantial fraction of FGD patients.",
keywords = "Familial glucocorticoid deficiency, In silico functional analysis, NNT",
author = "Rie Yamaguchi and Fumiko Kato and Tomonobu Hasegawa and Noriyuki Katsumata and Maki Fukami and Toshiharu Matsui and Keisuke Nagasaki and Tsutomu Ogata",
year = "2013",
doi = "10.1507/endocrj.EJ13-0024",
language = "English",
volume = "60",
pages = "855--859",
journal = "Endocrine Journal",
issn = "0918-8959",
publisher = "Japan Endocrine Society",
number = "7",

}

TY - JOUR

T1 - A novel homozygous mutation of the nicotinamide nucleotide transhydrogenase gene in a Japanese patient with familial glucocorticoid deficiency

AU - Yamaguchi, Rie

AU - Kato, Fumiko

AU - Hasegawa, Tomonobu

AU - Katsumata, Noriyuki

AU - Fukami, Maki

AU - Matsui, Toshiharu

AU - Nagasaki, Keisuke

AU - Ogata, Tsutomu

PY - 2013

Y1 - 2013

N2 - Familial glucocorticoid deficiency (FGD) is a rare autosomal recessive disorder characterized by primary hypocortisolism and normal mineralocorticoid production. Recently, NNT encoding the nicotinamide nucleotide transhydrogenase has been identified as a causative gene for FGD. Thus, we examined NNT in six Japanese FGD patients with no recognizable mutation in the previously known four responsible genes for FGD (MC2R, MRAP, STAR, and MCM4), and identified a novel homozygous substitution (c.644T>C; p.Phe215Ser) in a single 17.5-year-old boy. His parents were heterozygous for this mutation. This substitution was absent from 120 Japanese control subjects and was not registered in public databases including JSNP Database. The phenylalanine residue at the 215th codon was evolutionally conserved, and the p.Phe215Ser was assessed to be a pathologic mutation by in silico protein function analyses. The results, in conjunction with the previous data, imply that NNT mutations account for 5-10% of FGD patients, and that underlying factor(s) still remains to be clarified in a substantial fraction of FGD patients.

AB - Familial glucocorticoid deficiency (FGD) is a rare autosomal recessive disorder characterized by primary hypocortisolism and normal mineralocorticoid production. Recently, NNT encoding the nicotinamide nucleotide transhydrogenase has been identified as a causative gene for FGD. Thus, we examined NNT in six Japanese FGD patients with no recognizable mutation in the previously known four responsible genes for FGD (MC2R, MRAP, STAR, and MCM4), and identified a novel homozygous substitution (c.644T>C; p.Phe215Ser) in a single 17.5-year-old boy. His parents were heterozygous for this mutation. This substitution was absent from 120 Japanese control subjects and was not registered in public databases including JSNP Database. The phenylalanine residue at the 215th codon was evolutionally conserved, and the p.Phe215Ser was assessed to be a pathologic mutation by in silico protein function analyses. The results, in conjunction with the previous data, imply that NNT mutations account for 5-10% of FGD patients, and that underlying factor(s) still remains to be clarified in a substantial fraction of FGD patients.

KW - Familial glucocorticoid deficiency

KW - In silico functional analysis

KW - NNT

UR - http://www.scopus.com/inward/record.url?scp=84880944060&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84880944060&partnerID=8YFLogxK

U2 - 10.1507/endocrj.EJ13-0024

DO - 10.1507/endocrj.EJ13-0024

M3 - Article

C2 - 23474776

AN - SCOPUS:84880944060

VL - 60

SP - 855

EP - 859

JO - Endocrine Journal

JF - Endocrine Journal

SN - 0918-8959

IS - 7

ER -